Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysisJoseph A. Pidala, Samantha Jaglowski, Jongphil Kim et al.|Blood Advances|2024Cited by 16
Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 StudyLeslie S. Kean, Susan DeWolf, Merav Bar et al.|Blood|2023Cited by 12
Corrigendum to: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532; Article Number: JTCT-S-25-00377Stephen R. Spellman, Mariam Allbee-Johnson, Ke Xu et al.|Transplantation and Cellular Therapy|2025Cited by 2
Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World AnalysisJoseph A. Pidala, Samantha Jaglowski, Mary E.D. Flowers et al.|Transplantation and Cellular Therapy|2024Cited by 0